Adoptive immunotherapy for head and neck cancer with killer cells induced by stimulation with autologous or allogeneic tumour cells and recombinant interleukin-2.

Source:http://linkedlifedata.com/resource/pubmed/id/2787951

Download in:

View as

General Info

PMID
2787951